Gastroesophageal Reflux Disease clinical trials at UC Irvine
2 in progress, 1 open to eligible people
Multicenter Single-Blind RCT of CTIF Versus LNF For Treatment of GERD in Patients Requiring Hiatal Hernia Repair
open to eligible people ages 22-80
This single-blind randomized control study will follow 142 subjects across 7 sites randomized on a 1:1 ratio to compare treatment efficacy and safety between TIF and LNF in GERD patients with hiatal hernia undergoing hernia repair.
Irvine, California and other locations
Sorry, accepting new patients by invitation only
A multi-center, multi-year registry of patients with gastroesophageal reflux disease (GERD) undergoing diagnostic evaluation and/or treatment of GERD and associated diseases and complications.
Orange, California and other locations
Our lead scientists for Gastroesophageal Reflux Disease research studies include Kenneth J Chang, MD.